trial · primary record
Senaparib
Ovary Cancer
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 18 |
| Primary completion | 2029-12 |
| Primary endpoint | Objective Response Rate (ORR) |
| Registry ID | NCT06617923 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:44:08.067Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06617923
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.